Dr. Phoebe E. Rabbin, MD

Dr. Rabbin practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Rabbin's NPI, 1023018801, was assigned on July 22, 2005. Dr. Rabbin graduated from State University of New York Downstate Medical Center College of Medicine in 1986. Dr. Rabbin holds New York license 171912.

Dr. Rabbin's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Rabbin's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Rabbin is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Rabbin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rabbin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rabbin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rabbin is licensed in New York.

CMS data shows 2,190 Medicare services from Dr. Rabbin across 13 procedure codes in 2024, for 709 Medicare patients. Medicare paid $136,705 for them. Every service was in an office.

CMS counts 709 Medicare patients who saw Dr. Rabbin in 2024. The largest group is 75 to 84, with 311 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rabbin's median patient age at 59, with 62% women.

In 2024, Dr. Rabbin wrote 751 Medicare Part D claims for 313 patients. 91% of them were for generic drugs. CMS names the drug for 657 of them, across 18 drugs with 11 or more claims each, at $23,871 in total drug cost. In 2023, CMS named 585 claims across 18 drugs.

Dr. Rabbin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rabbin as offering telehealth. CMS counts 169 procedures of skin biopsy by Dr. Rabbin, more than 82% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 5 general payments to Dr. Rabbin from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Galderma Laboratories, L.P. paid the most, $27.

Dr. Rabbin graduated from State University of New York Downstate Medical Center College of Medicine in 1986.